MHC class II-deficient tumor cell lines with a defective expression of the class II transactivator.
Naves R, Lennon AM, Barbieri G, Reyes L, Puga G, Salas L, Deffrennes V, Rosemblatt M, Fellous M, Charron D, Alcaïde-Loridan C, Bono MR.
Naves R, et al. Among authors: rosemblatt m.
Int Immunol. 2002 May;14(5):481-91. doi: 10.1093/intimm/14.5.481.
Int Immunol. 2002.
PMID: 11978778